CAS#:170851-70-4
Ipamorelin
Size
Research Profile
Ipamorelin
Literature-based research context for laboratory reference only.
Ipamorelin is a pentapeptide ghrelin receptor agonist developed by Novo Nordisk. It selectively stimulates GH release with minimal effect on cortisol or prolactin, making it a widely used research compound for studying the ghrelin axis and GH secretagogue receptor biology.
Selected literature
- Raun et al., 1998, European Journal of Endocrinology.
This page is provided for laboratory reference and literature review only. The material is not presented as a consumer product, medical treatment, diagnostic tool, or recommendation for human or animal use.
Overview
Ipamorelin is presented here as a laboratory reference entry. The Research Profile summarizes literature-based biological context, while this Overview documents the identity record, specification set, preparation format, and quality-reference information available on the page.
The identity block lists CAS number 170851-70-4, molecular formula C₃₈H₄₉N₉O₅, and molecular weight 711.9 Da. The material record is paired with ≥99% purity information and a lyophilized presentation for reference review.
Available specification labels include 2mg, 5mg, and 10mg. The active selection is 2mg; changing the selector updates the visible specification label and COA lot references while preserving the same research-reference context.
For the active selection, the page currently shows 1 active COA lot reference. COA links, when present, are retained for batch-level purity, identity, and quantity review, while packaging and storage details remain separated in Structure & Identity.